4.5 Oesophageal, Gastric and Pancreatic Cancer
Key Takeaways
Use the Irish P1 pathway for stable alarm symptoms and the emergency pathway for severe acute swallowing difficulty or significant acute bleeding.
Use endoscopic tissue for diagnosis and specialist staging tests to decide which treatments are possible.
In stable suspected pancreatic cancer with obstruction, plan dedicated CT before elective drainage. Treat acute cholangitis as an emergency.
Choose the urgency and first investigation
Ask what happens when the patient tries to swallow. Coughing, choking or difficulty initiating a swallow points towards an oropharyngeal problem that may require airway protection or a swallowing assessment. Food that seems to stick after the swallow suggests an oesophageal cause. Progressive difficulty with solids and then liquids raises concern for fixed narrowing. Cancer is one cause, with stricture and other lesions in the differential. Dysphagia for solids and liquids from the start can suggest disordered motility, although the history alone cannot exclude cancer. Ask about progression, hydration, regurgitation, odynophagia, weight change, previous reflux and bleeding. Examine for dehydration, pallor, lymphadenopathy and an abdominal mass. Provide enough clinical detail for triage and assess nutrition while the investigation proceeds.
| Clinical picture | Initial decision |
|---|---|
| Significant acute upper gastrointestinal bleeding or severe acute swallowing difficulty | Emergency assessment. Resuscitate and assess airway or aspiration risk where relevant. |
| Stable progressive oesophageal dysphagia, progressive unexplained weight loss with upper GI symptoms or new early satiety | Refer via the Irish HSE urgent P1 upper GI pathway. It aims for urgent review and/or endoscopy within four weeks. |
| New or worsening dyspepsia without alarm symptoms | Use the Irish endoscopy triage criteria. Age, persistence and risk factors affect referral. In younger low-risk patients, a dyspepsia pathway can include testing for H. pylori or an empirical proton pump inhibitor. Reassess if symptoms persist or alarm features arise. |
Gastric cancer can present with persistent upper abdominal symptoms, early satiety, weight loss, anaemia or bleeding. A palpable epigastric mass warrants urgent assessment and may arise from several organs. Baseline blood counts, iron indices when indicated, renal and liver function can identify complications and help triage. Upper GI endoscopy enables inspection and biopsy. An empirical treatment response or a normal haemoglobin cannot safely rule out malignancy in a patient with progressive dysphagia.
HIQA upper GI referral guidance, section 2.5 · UEG/ESNM dysphagia recommendations · HSE cancer symptoms · ESMO living guideline, November 2026.
A 64-year-old has six weeks of progressive retrosternal food sticking. This started with bread and meat and now also occurs with liquids. There is unintentional weight loss. He can still take fluids and handle secretions and has no acute bleeding or respiratory distress. What should his GP arrange?
A routine review after an empirical course of acid suppression
An urgent P1 upper GI referral for assessment and endoscopy, with biopsy of a suspicious lesion
Faecal immunochemical testing as the initial investigation
Supplements and observation until anaemia develops
Distinguish a tissue diagnosis from staging and treatment planning
Biopsy establishes the histological type, which matters across the oesophagus, gastro-oesophageal junction and stomach. For example, oesophageal squamous carcinoma and gastro-oesophageal adenocarcinoma follow different treatment pathways. Obtain adequate endoscopic samples. Contrast-enhanced cross-sectional imaging looks for nodal and distant involvement. The team can use endoscopic ultrasound when local depth or nodal detail would change a treatment plan, PET–CT in selected oesophageal cases and staging laparoscopy in selected gastric cancers where detecting peritoneal disease changes management. Use the investigations that answer the next clinical question. A suspicious lesion on staging imaging can require further clarification if it would change whether treatment is potentially curative.
The multidisciplinary team reviews histology, stage, fitness and nutrition. Selected superficial disease can be treated endoscopically. For more advanced localised disease, options include surgery with perioperative treatment or chemoradiotherapy, depending on site, extent and histology. In advanced gastro-oesophageal adenocarcinoma, biomarkers such as HER2 and PD-L1 can guide systemic treatment. Support nutrition, manage pain and obstruction, and clarify treatment goals at each stage.
Irish NCEC oesophageal and junctional cancer guideline · ESMO 2026 gastric and oesophageal guideline.
Investigate possible pancreatic malignancy with biliary obstruction
Painless jaundice with dark urine, pale stools, pruritus and weight loss can reflect obstruction from a tumour in the pancreatic head. A patient can also present with weight loss and persistent epigastric or back pain without jaundice. Stones and other causes of biliary narrowing remain possible, so document the tempo, pain, fever and systemic signs. A cholestatic liver panel supports obstruction. Ultrasound can show duct dilatation and gallbladder stones but cannot always determine the cause or adequately visualise the pancreas.
For a stable patient with suspected pancreatic cancer and obstructive jaundice, ESMO and NICE recommend a dedicated multiphasic pancreatic protocol CT before planned biliary drainage. CT also assesses vascular involvement and visible metastases. Suspected acute cholangitis requires emergency treatment and urgent assessment for drainage. A planned cancer staging sequence must not delay that emergency pathway.
A specialist pancreatic multidisciplinary team reviews possible resectability, the reason for drainage and the need for tissue. If CT leaves a diagnostic question, MRI or endoscopic ultrasound can add information. Endoscopic ultrasound can obtain tissue when required, including before planned systemic therapy. Routine preoperative drainage is avoided in suitable patients proceeding directly to surgery, with decisions made in context. CA 19-9 can help assess a known cancer but can rise with benign biliary obstruction. It cannot confirm or exclude the diagnosis on its own. In unresectable or metastatic disease, align disease-directed options and measures such as symptom relief, nutrition and pancreatic enzyme replacement with the patient's circumstances.
HSE cancer symptoms · ESMO pancreatic cancer guideline · NICE NG85 pancreatic cancer diagnosis and treatment.
A 70-year-old has three weeks of painless jaundice, pale stools and weight loss. Ultrasound shows dilated bile ducts but cannot define the cause. He is afebrile and haemodynamically stable, without rigors or other clinical evidence of cholangitis. His renal function permits contrast. Which investigation should guide planning before elective drainage for suspected pancreatic cancer?
Serum CA 19-9 as a stand-alone diagnostic test
Immediate elective biliary stenting followed by the first staging scan
A repeat ultrasound in three months
A pancreatic protocol contrast-enhanced CT
Sections you finish are checked off in the contents.